Salarius Pharmaceuticals, Inc. (SLRX)

NASDAQ: SLRX · IEX Real-Time Price · USD

2.200

-0.020 (-0.90%)

At close: Jul 2, 2024, 3:59 PM

2.160

-0.040 (-1.82%)

After-hours: Jul 2, 2024, 7:56 PM EDT

Salarius Pharmaceuticals Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2015
Revenue	0	0	1.84	5.23	3.47	Upgrade
Revenue Growth (YoY)	-	-	-64.84%	51.03%	77.57%	Upgrade
Gross Profit	0	0	1.84	5.23	3.47	Upgrade
Selling, General & Admin	5.72	7.14	6.1	6.11	7.71	Upgrade
Research & Development	7.17	15.84	8.55	6.91	4.02	Upgrade
Other Operating Expenses	0	8.87	0	0	0	Upgrade
Operating Expenses	12.89	31.84	14.65	13.02	11.73	Upgrade
Operating Income	-12.89	-31.84	-12.81	-7.79	-8.27	Upgrade
Interest Expense / Income	0	0	0	0	-0.02	Upgrade
Other Expense / Income	-0.35	-0.23	-0.04	-0.43	-1.31	Upgrade
Pretax Income	-12.54	-31.61	-12.77	-7.35	-6.94	Upgrade
Net Income	-12.54	-31.61	-12.77	-7.35	-6.94	Upgrade
Preferred Dividends	0	0	0	0.4	0	Upgrade
Net Income Common	-12.54	-31.61	-12.77	-7.75	-6.94	Upgrade
Shares Outstanding (Basic)	0	0	0	0	0	Upgrade
Shares Outstanding (Diluted)	0	0	0	0	0	Upgrade
Shares Change	53.66%	28.40%	165.53%	376.61%	112.33%	Upgrade
EPS (Basic)	-30.72	-119.04	-61.76	-100.00	-424.00	Upgrade
EPS (Diluted)	-30.72	-119.04	-61.76	-100.00	-424.00	Upgrade
Free Cash Flow	-12.85	-17.6	-10.2	-10.31	-11.58	Upgrade
Free Cash Flow Per Share	-31.48	-66.26	-49.32	-132.41	-708.56	Upgrade
Gross Margin	-	-	100.00%	100.00%	100.00%	Upgrade
Operating Margin	-	-	-696.27%	-148.78%	-238.53%	Upgrade
Profit Margin	-	-	-693.84%	-148.06%	-200.18%	Upgrade
Free Cash Flow Margin	-	-	-554.29%	-197.08%	-334.20%	Upgrade
EBITDA	-12.53	-31.6	-12.75	-7.33	-6.82	Upgrade
EBITDA Margin	-	-	-692.80%	-140.14%	-196.95%	Upgrade
Depreciation & Amortization	0.01	0.01	0.02	0.02	0.13	Upgrade
EBIT	-12.54	-31.61	-12.77	-7.35	-6.95	Upgrade
EBIT Margin	-	-	-693.84%	-140.49%	-200.63%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).